228 related articles for article (PubMed ID: 32857679)
1. Is There a Rationale for Using
Maheshwari N; Jain A
Viral Immunol; 2021 Jun; 34(5):300-306. PubMed ID: 32857679
[TBL] [Abstract][Full Text] [Related]
2. Potential role of Bacillus Calmette-Guérin (BCG) vaccination in COVID-19 pandemic mortality: Epidemiological and Immunological aspects.
Charoenlap S; Piromsopa K; Charoenlap C
Asian Pac J Allergy Immunol; 2020 Sep; 38(3):150-161. PubMed ID: 32686943
[TBL] [Abstract][Full Text] [Related]
3. Relationship between Bacillus Calmette Guerin Vaccination Policy and Coronavirus Disease-2019 (COVID-19) Incidence.
Alyasin S; Kanannejad Z; Esmaeilzadeh H; Nabavizadeh H; Ghatee MA; Amin R
Iran J Allergy Asthma Immunol; 2021 Feb; 20(1):106-113. PubMed ID: 33639625
[TBL] [Abstract][Full Text] [Related]
4. Are BCG-induced non-specific effects adequate to provide protection against COVID-19?
Vashishtha VM
Hum Vaccin Immunother; 2021 Jan; 17(1):88-91. PubMed ID: 32762516
[TBL] [Abstract][Full Text] [Related]
5. Avoiding COVID-19 complications with diabetic patients could be achieved by multi-dose Bacillus Calmette-Guérin vaccine: a case study of beta cells regeneration.
Ayoub BM; Ramadan E; Ashoush N; Tadros MM; Hendy MS; Elmazar MM; Mousa SA
Pharmazie; 2020 Aug; 75(8):375-380. PubMed ID: 32758336
[TBL] [Abstract][Full Text] [Related]
6. COVID-19 pandemic: SARS-CoV-2 specific vaccines and challenges, protection via BCG trained immunity, and clinical trials.
Gong W; Aspatwar A; Wang S; Parkkila S; Wu X
Expert Rev Vaccines; 2021 Jul; 20(7):857-880. PubMed ID: 34078215
[No Abstract] [Full Text] [Related]
7. The BCG Vaccine for COVID-19: First Verdict and Future Directions.
Gonzalez-Perez M; Sanchez-Tarjuelo R; Shor B; Nistal-Villan E; Ochando J
Front Immunol; 2021; 12():632478. PubMed ID: 33763077
[TBL] [Abstract][Full Text] [Related]
8. Is the BCG vaccine a useful tool against COVID-19?
Zhelezova G; Mateeva V; Mateev G
Clin Dermatol; 2021; 39(1):98-103. PubMed ID: 33972060
[TBL] [Abstract][Full Text] [Related]
9. The influence of vaccination against tuberculosis with the Bacillus-Calmette-Guérin(BCG) vaccine on COVID-19 incidence and mortality - review of the literature.
Ręka G; Korzeniowska A; Piecewicz-Szczęsna H
Przegl Epidemiol; 2020; 74(2):290-302. PubMed ID: 33115218
[TBL] [Abstract][Full Text] [Related]
10. Role of latent tuberculosis infections in reduced COVID-19 mortality: Evidence from an instrumental variable method analysis.
Takahashi H
Med Hypotheses; 2020 Nov; 144():110214. PubMed ID: 33254521
[TBL] [Abstract][Full Text] [Related]
11. Using BCG vaccine to enhance non-specific protection of health care workers during the COVID-19 pandemic: A structured summary of a study protocol for a randomised controlled trial in Denmark.
Madsen AMR; Schaltz-Buchholzer F; Benfield T; Bjerregaard-Andersen M; Dalgaard LS; Dam C; Ditlev SB; Faizi G; Johansen IS; Kofoed PE; Kristensen GS; Loekkegaard ECL; Mogensen CB; Mohamed L; Ostenfeld A; Oedegaard ES; Soerensen MK; Wejse C; Jensen AKG; Nielsen S; Krause TG; Netea MG; Aaby P; Benn CS
Trials; 2020 Sep; 21(1):799. PubMed ID: 32943115
[TBL] [Abstract][Full Text] [Related]
12. Convergence between global BCG vaccination and COVID-19 pandemic.
Islam MZ; Zahan MK; Al-Bari MAA
J Med Virol; 2021 Mar; 93(3):1496-1505. PubMed ID: 32827313
[TBL] [Abstract][Full Text] [Related]
13. Bacillus calmette-guerin as a quick and temporary solution to coronavirus disease-2019.
Kumari P; Gupta UD; Bhagyawant SS
Int J Mycobacteriol; 2021; 10(2):105-110. PubMed ID: 34558459
[TBL] [Abstract][Full Text] [Related]
14. BCG vaccination history associates with decreased SARS-CoV-2 seroprevalence across a diverse cohort of health care workers.
Rivas MN; Ebinger JE; Wu M; Sun N; Braun J; Sobhani K; Van Eyk JE; Cheng S; Arditi M
J Clin Invest; 2021 Jan; 131(2):. PubMed ID: 33211672
[TBL] [Abstract][Full Text] [Related]
15. Lessons From Bacille Calmette-Guérin for SARS-CoV-2 Vaccine Candidates.
Behr MA; Divangahi M; Schurr E
J Infect Dis; 2021 Feb; 223(2):189-191. PubMed ID: 33535239
[TBL] [Abstract][Full Text] [Related]
16. BCG vaccination and the risk of COVID 19: A possible correlation.
Ahmed SM; Nasr MA; Elshenawy SE; Hussein AE; El-Betar AH; Mohamed RH; El-Badri N
Virology; 2022 Jan; 565():73-81. PubMed ID: 34742127
[TBL] [Abstract][Full Text] [Related]
17. Lessons from Bacillus Calmette-Guérin: Harnessing Trained Immunity for Vaccine Development.
Pasco ST; Anguita J
Cells; 2020 Sep; 9(9):. PubMed ID: 32948003
[TBL] [Abstract][Full Text] [Related]
18. Impact of Routine Infant BCG Vaccination on COVID-19.
Kinoshita M; Tanaka M
J Infect; 2020 Oct; 81(4):625-633. PubMed ID: 32795481
[TBL] [Abstract][Full Text] [Related]
19. Can BCG be useful to mitigate the COVID-19 pandemic? A Canadian perspective.
De Wals P; Menzies D; Divangahi M
Can J Public Health; 2020 Dec; 111(6):939-944. PubMed ID: 33211246
[TBL] [Abstract][Full Text] [Related]
20. BCG vaccine protection from severe coronavirus disease 2019 (COVID-19).
Escobar LE; Molina-Cruz A; Barillas-Mury C
Proc Natl Acad Sci U S A; 2020 Jul; 117(30):17720-17726. PubMed ID: 32647056
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
